14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
On Monday, August 8th, the Deputy Director of Legislative Affairs of the Department of Managed Healt...
Read More >
Private equity (PE) investment in physician groups has steadily grown over the last several years, w...
Read More >
Concrete Contractor Fired Secretary Who Opposed Racial Slurs, Federal Agency Says - BALTIMORE - Ba...
Read More >
In April 2011, the U.S. Department of Labor (DOL) requested information from the public on how the D...
Read More >
The COVID-19 pandemic is impacting every facet of the economy, including commercial construction and...
Read More >
Seyfarth Synopsis: The SECURE Act—just signed into law late last week—includes probably the most c...
Read More >